Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
Neurofascin 140 is an embryonic neuronal neurofascin isoform that promotes the assembly of the node of ranvier.
Poster Abstracts from the Fourth International Symposium on Gait and Balance in Multiple Sclerosis: The Role of CognitionCleveland Clinic • Cleveland, Ohio, USA • October 10 & 11, 2014.
Estimating the marginal effect of socioeconomic factors on the demand of specialty drugs.
Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages.
Implementing technology-based embedded assessment in the home and community life of individuals aging with disabilities: a participatory research and development study.
Resting-state functional connectivity in multiple sclerosis: An examination of group differences and individual differences.
Roles for HB-EGF and CD9 in multiple sclerosis.
Intraoperative smile in a multiple sclerosis patient with medication-refractory tremor.
Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely.
Targeting molecules to medicine with mTOR, autophagy, and neurodegenerative disorders.
Neurodegenerative Diseases: from available treatments to prospective herbal therapy.
A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis.
Assessment of urinary incontinence in the women in Eastern Turkey.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis.
Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients.
Multiple sclerosis: Quadrivalent HPV vaccination does not increase risk of MS.
Autophagy and neurodegeneration.
Pages
« first
‹ previous
…
477
478
479
480
481
482
483
484
485
…
next ›
last »